Skip to content

End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach

End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06551831
Enrollment
30
Registered
2024-08-13
Start date
2024-07-23
Completion date
2025-07-31
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-of-life Decision-making

Keywords

Young Patients, Advanced Cancer, Grounded Theory

Brief summary

The purpose of this qualitative research is to use grounded theory to explore and describe the thoughts of young advanced cancer patients regarding end-of-life care and how these thoughts influence the related decision-making process.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* The patient has a solid tumor. * The age at initial cancer diagnosis is between 15 and 39 years. * The patient is at least 18 years old at the time of enrollment. * The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up. * After metastasis, the first-line curative treatment is ineffective.

Exclusion criteria

\- Patients who, for any reason, including severe psychological distress (as determined by the attending physician, psychiatrist, or specialist nurse based on assessments and impressions during routine patient care), cognitive impairment, or physical limitations (such as frailty), are unable to communicate or participate in an interview lasting more than 30 minutes.

Design outcomes

Primary

MeasureTime frameDescription
Interview Guide2024/7~2025/71.The journey since diagnosis. 2. The most profound or recent medical decision. 3. The most profound or recent medical decision. 4. Anticipated future medical decisions. 5. Future end-of-life care options

Countries

Taiwan

Contacts

Primary ContactPei-Yu Hsu
020854@ntuh.gov.tw+886-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026